We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

In Vitro Maturation of Immature Oocytes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00480337
First Posted: May 30, 2007
Last Update Posted: December 17, 2008
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Sheba Medical Center
May 29, 2007
May 30, 2007
December 17, 2008
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00480337 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
In Vitro Maturation of Immature Oocytes
Not Provided
The aim of this study is to aspirate immature oocytes from antral follicles and mature the oocytes in vitro. These mature oocytes will serve for fertilization and the creation of embryos which will be replace in the uterus as performed during normal IVF.We will record the efficacy and safety of this procedure.
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Polycystic Ovary Syndrome
  • Ovarian Hyperstimulation Syndrome
Procedure: In Vitro Maturation of immature oocytes
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Women with PCOS
  • Women with previous Hyperstimulation or with risk of developing hyperstimulation during IVF Treatment
  • Women diagnosed with cancer who are interested in fertility preservation
  • Women with repeated IVF failure

Exclusion Criteria:

  • Severe cases of endometriosis
  • Large myomas
  • Hydrosalpinxs Technical problem with previous oocytes pick-up
Sexes Eligible for Study: Female
20 Years to 45 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
 
NCT00480337
SHEBA-06-4317-AH-CTIL
No
Not Provided
Not Provided
Not Provided
Sheba Medical Center
Not Provided
Principal Investigator: Ariel Hourvitz IVF Unit, Sheba Medical Center
Sheba Medical Center
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP